Using CD40-activated B cells to efficiently identify epitopes of tumor antigens

Journal of Immunotherapy

Volumn 32, Issue 2, 2009, Pages 157-160

  Kondo, Eisei ^a   Gryschok, Luise ^a   Schultze, Joachim L ^a   Von Bergwelt Baildon, Michael S ^a,b,c  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Antigen presenting cell; Epitope; T cell expansion; Tumor antigen

Indexed keywords

CD40 ANTIGEN; CYCLINE; EPITOPE; TUMOR ANTIGEN;

ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE; ALGORITHM; AMINO ACID SEQUENCE; CHEMISTRY; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY;

ALGORITHMS; AMINO ACID SEQUENCE; ANTIGENS, CD40; ANTIGENS, NEOPLASM; B-LYMPHOCYTES; CYCLINS; EPITOPE MAPPING; EPITOPES; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 63649158209     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e31819031a2     Document Type: Article

References (15)

1. Kessler JH, Melief CJ. Identification of T-cell epitopes for cancer immunotherapy. Leukemia. 2007;21:1859-1874.
2. Vonderheide RH, Hahn WC, Schultze JL, et al. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity. 1999;10:673-679.
3. Maecker B, Sherr DH, Vonderheide RH, et al. The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells. Blood. 2003;102:3287-3294.
4. Hirano N, Butler MO, Von Bergwelt-Baildon MS, et al. Autoantibodies frequently detected in patients with aplastic anemia. Blood. 2003;102:4567-4575.
5. Kondo E, Akatsuka Y, Kuzushima K, et al. Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles. Blood. 2004;103:630-638.
6. von Bergwelt-Baildon MS, Vonderheide RH, Maecker B, et al. Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application. Blood. 2002;99:3319-3325.
7. Hirano N, Butler MO, Xia Z, et al. Identification of an immunogenic CD8+ T-cell epitope derived from gamma-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia. Blood. 2006; 108:2662-2668.
8. Lapointe R, Bellemare-Pelletier A, Housseau F, et al. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Cancer Res. 2003;63:2836-2843.
9. Wiesner M, Zentz C, Mayr C, et al. Conditional Immortalization of Human B Cells by CD40 Ligation. PLoS ONE. 2008; 3:e1464.
10. Tu W, Lau YL, Zheng J, et al. Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells. Blood. 2008;1 12:2554-2562.
11. Sicinski P, Donaher JL, Geng Y, et al. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature. 1996;384:470-474.
12. Kao H, Marto JA, Hoffmann TK, et al. Identification of Cyclin B1 as a Shared Human Epithelial Tumor-Associated Antigen Recognized by T Cells. J Exp Med. 2001;194: 1313-1324.
13. Gao L, Yang TH, Tourdot S, et al. Allo-major histocompat-ibility complex-restricted cytotoxic T lymphocytes engraft in bone marrow transplant recipients without causing graft-versus-host disease. Blood. 1999;94:2999-3006.
14. Egloff AM, Vella LA, Finn OJ. Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer. Cancer Res. 2006;66:6-9.
15. Coughlin CM, Vance BA, Grupp SA, et al. RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy. Blood. 2004;103:2046-2054.